Skip to main content
Shahzad Raza, MD, Oncology, Cleveland, OH

ShahzadRazaMD

Oncology Cleveland, OH

Hematologic Oncology

Multiple Myeloma & AL Amyloidosis Program Staff Physician

Dr. Raza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Raza's full profile

Already have an account?

Education & Training

  • Washington University St Louis
    Washington University St Louis Stem Cell Transplant, Fellow , 2014 - 2015
  • University of Missouri-Columbia
    University of Missouri-ColumbiaFellowship, Hematology and Medical Oncology, 2012 - 2015
  • One Brooklyn Health System/Brookdale University Hospital and Medical Center
    One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2009 - 2012
  • Dow University of Health Sciences
    Dow University of Health SciencesClass of 2004

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2014 - 2025
  • OH State Medical License
    OH State Medical License 2022 - 2024
  • KS State Medical License
    KS State Medical License 2017 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors CASTLE CONNOLLY, 2022-2023
  • Teacher of the year Columbia University, 2017
  • FACP Fellow of the American College of Physician, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review  
    Razwana Khanam, Beth Faiman, Saba Batool, Mohammed Musa Najmuddin 4, Rana Usman 5 , Kiran Kuriakose 6, Arooj Ahmed 7, Mohammad Ebad Ur Rehman 8, Zinath Roksana 9 , Zai..., Journal of Clinical Medicine, 8/25/2023
  • Systemic AL amyloidosis: current approach and future direction  
    Maroun Bou Zerdan1, Lewis Nasr2, Farhan Khalid3, Sabine Allam4, Youssef Bouferraa5, Saba Batool6, Muhammad Tayyeb7, Shubham Adroja8, Mahinbanu Mammadii1, Faiz Anwer9, ..., Oncotarget. 2023; 14:384-394, 4/26/2023
  • Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice  
    Danai Dima 1,*ORCID, Fauzia Ullah 1, Sandra Mazzoni 1ORCID, Louis Williams 1, Beth Faiman 1, Austin Kurkowski 2, Chakra Chaulagain 3ORCID, Shahzad Raza 1ORCID, Christy..., Cancers 2023, 15(7), 2160
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Disparities in multiple myeloma : A global perspective on drug toxicity trends
    Majid Jaberi- Douraki, Xuan Xu, Beth Faiman, Gerald Wyckoff, Jim Riviere, Jack Khouri, Sandra Ann Mazzoni, Remya Ampadi Ramachandran, Nuwan Millagaha Gadara, Mobina Go..., 2023 Annual American Society of Clinical Oncology Oral Poster Discussion, J Clin Oncol 41, 2023 ( suppl 16; abstr 8015), 6/5/2023
  • Disparities in multiple myeloma: A global perspective on drug toxicity trends.
    Majid Jaberi-Douraki, Xuan Xu, Beth Faiman, Gerald Wyckoff, Jim Riviere, Jack Khouri, Sandra Ann Mazzoni, Remya Ampadi Ramachandran, Nuwan Millagaha Gadara, Mobina Gol..., American Society of Clinical Psychology Oncology 2023, Chicago, 6/5/2023
  • Identification of genes encoding targets associated with adverse events in multiple myeloma
    Xuan Xu, Shahzad Raza, Nuwan Millagaha Gadara, Remya Ampadi Ramachandran, Jim Riviere, Mobina Golmohammadi, Gerald Wyckoff, Beth Faiman, Faiz Anwer, Ashiq Masood, Jack..., 2023 Annual ASCO Meeting, Poster Presentation, J Clin Oncol 41, 2023 (suppl 16; abstr 1556), 6/5/2023
  • Join now to see all

Authored Content

  • Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeApril 2023

Press Mentions

  • KSHB: Immunotherapy Helps Local Woman Beat Uncommon Form of Cancer
    KSHB: Immunotherapy Helps Local Woman Beat Uncommon Form of CancerApril 24th, 2019
  • Race Could Be a Factor in Head, Neck Cancer Survival Rates
    Race Could Be a Factor in Head, Neck Cancer Survival RatesJune 5th, 2014

Research History

  • Principle InvestigatorMultiple Myeloma and AL Amyloidosis , Malignant Lymphomas Clinical trials2017 - Present
  • Principal investigator at Columbia UniversityDaratumumab, lenalidomide and dexamethasone in transplant ineligible newly diagnosed multiple myeloma2016 - 2017
  • Principal investigator at Columbia UniversityPembrolizumab and Pomalidomdie in Multiple Myeloma2016 - 2017
  • Co-InvestigatorRole of monoclonal antibody 11-1F4 in systemic AL Amyloidosis2015 - 2017
  • Co- InvestigatorCarfilzomib, bendamustine and dexamethasone in newly diagnosed Multiple Myeloma2015 - 2017
  • Research AssociateAngiogenesis in CNS malignancies2007 - 2009

Professional Memberships

Other Languages

  • Hindi, Gujarati, Urdu